Placental pathology in early-onset and late-onset fetal growth restriction

Fetal Diagnosis and Therapy

Volumn 36, Issue 2, 2014, Pages 117-128

  Mifsud, William ^a   Sebire, Neil J ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Growth restriction; Placental pathology; Pre eclampsia

Indexed keywords

ARTERY DISEASE; CHEMICAL ANALYSIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; FETAL GROWTH RESTRICTION; HISTOPATHOLOGY; HUMAN; INTRAUTERINE GROWTH RETARDATION; ISCHEMIA; MATERNAL SERUM; MEDICAL EXAMINATION; MORPHOLOGY; ONSET AGE; PARENCHYMA; PATHOLOGY; PLACENTA; PLACENTA PERFUSION; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; TROPHOBLAST; UMBILICAL ARTERY; UTERINE ARTERY; VASCULAR DISEASE; DOPPLER FLOWMETRY; PATHOPHYSIOLOGY; PLACENTA DISORDER; POSITRON EMISSION TOMOGRAPHY; PREMATURITY; FEMALE; FETUS; FETUS DEVELOPMENT; PREGNANCY;

FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; FETUS; HUMANS; PLACENTA; PREGNANCY;

EID: 84908356099     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000359969     Document Type: Review

References (108)

1. Fox H, Sebire NJ: The placenta in abnormalities and disorders of the fetus; in Fox H, Sebire NJ (eds): Pathology of the Placenta: Major Problems in Pathology 7, ed 3. Philadelphia, Saunders Elsevier, 2007.
2. Wigglesworth JS: The gross and microscopic pathology of the prematurely delivered placenta. J Obstet Gynaecol Br Emp 1962; 69: 934-943.
3. Wigglesworth JS: Morphological variations in the insufficient placenta. J Obstet Gynaecol Br Commonw 1964; 71: 871-884.
4. Wong TC, Latour JP: Microscopic measurement of the placental components in an attempt to assess the malnourished newborn infant. Am J Obstet Gynecol 1966; 94: 942-950.
5. Altshuler G, Russell P, Ermocilla R: The placental pathology of small-for-gestational age infants. Am J Obstet Gynecol 1975; 121: 351-359.
6. Sandstedt B: The placenta and low birth weight. Curr Top Pathol 1979; 66: 1-55.
7. Driscoll SG: Placental lesions. Clin Perinatol 1979; 6: 397-402.
8. Bjoro K: Gross pathology of the placenta in intrauterine growth restriction. Ann Chir Gynaecol 1981; 70: 316-322.
9. Garcia AG: Placental morphology of lowbirth-weight infants born at term. Contrib Gynecol Obstet 1982; 9: 100-112.
10. Rayburn W, Sander C, Compton A: Histologic examination of the placenta in the growthretarded fetus. Am J Perinatol 1989; 6: 58-61.
11. Salafia CM, Vintzileos AM, Silberman L, Bantham KF, Vogel CA: Placental pathology of idiopathic intrauterine growth retardation at term. Am J Perinatol 1992; 9: 179-184.
12. Salafia CM, Minior VK, Pezzullo JC, Popek EJ, Rosenkrantz TS, Vintzileos AM: Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. Am J Obstet Gynecol 1995; 173: 1049-1057.
13. Oliveira LH, Xavier CC, Lana AMA: Changes in placental morphology of small for gestational age newborns (in Portuguese). J Pediatr (Rio J) 2002; 78: 397-402.
14. Park S-Y, Kim MY, Kim YJ, Chun YK, Kim HS, Hong SR: Placental pathology in intrauterine growth retardation. Korean J Pathol 2002; 36: 30-37.
15. Sheppard BL, Bonnar JJ: An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynaecol 1981; 88: 695-705.
16. Labarrere CC, Althabe OO, Telenta MM: Chronic villitis of unknown aetiology in placentae of idiopathic small for gestational age infants. Placenta 1982; 3: 309-317.
17. Van der Veen F, Fox H: The human placenta in idiopathic intrauterine growth retardation: a light and electron microscopic study. Placenta 1983; 4: 65-77.
18. Teasdale F: Idiopathic intrauterine growth retardation: histomorphometry of the human placenta. Placenta 1984; 5: 83-92.
19. Bjoro K, Myhre E: The role of chronic nonspecific inflammatory lesions of the placenta in intra-uterine growth retardation. Acta Pathol Microbiol Immunol Scand A 1984; 92: 133-137.
20. Boyd PA, Scott A: Quantitative structural studies on human placentas associated with pre-eclampsia, essential hypertension and intrauterine growth retardation. Br J Obstet Gynaecol 1985; 92: 714-721.
21. Macara L, Kingdom JC, Kaufmann P, Kohnen G, Hair J, More IA, Lyall F, Greer IA: Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. Placenta 1996; 17: 37-48.
22. Krebs C, Macara LM, Leiser R, Bowman AW, Greer IA, Kingdom JC: Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol 1996; 175: 1534-1542.
23. Todros T, Sciarrone A, Piccoli E, Guiot C, Kaufmann P, Kingdom J: Umbilical Doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction. Obstet Gynecol 1999; 93: 499-503.
24. Saol S, Saol O, Ozdemir N: Stereological quantification of placental villus vascularization and its relation to umbilical artery Doppler flow in intrauterine growth restriction. Prenat Diagn 2002; 22: 398-403.
25. Mayhew TM, Ohadike C, Baker PN, Crocker IP, Mitchell C, Ong SS: Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta 2003; 24: 219-226.
26. Brosens IA, Robertson WB, Dixon HG: The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972; 1: 177-191.
27. Gerretsen GG, Huisjes HJ, Elema JD: Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol 1981; 88: 876-881.
28. Khong TY, De Wolf F, Robertson WB, Brosens I: Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93: 1049-1059.
29. Olofsson P, Laurini RN, Marsál K: A high uterine artery pulsatility index reflects a defective development of placental bed spiral arteries in pregnancies complicated by hypertension and fetal growth retardation. Eur J Obstet Gynecol Reprod Biol 1993; 49: 161-168.
30. Ferrazzi E, Bulfamante G, Mezzopane R, Barbera A, Ghidini A, Pardi G: Uterine Doppler velocimetry and placental hypoxic-ischemic lesion in pregnancies with fetal intrauterine growth restriction. Placenta 1999; 20: 389-394.
31. De Wolf F, Brosens I, Renaer M: Fetal growth retardation and the maternal arterial supply of the human placenta in the absence of sustained hypertension. Br J Obstet Gynaecol 1980; 87: 678-685.
32. Naeye RL: Pregnancy hypertension, placental evidences of low uteroplacental blood flow, and spontaneous premature delivery. Hum Pathol 1989; 20: 441-444.
33. Voigt HJ, Becker V: Doppler flow measurements and histomorphology of the placental bed in uteroplacental insufficiency. J Perinat Med 1992; 20: 139-147.
34. Roberts JM, Redman CW: Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341: 1447-1451.
35. Salafia CM, Pezzullo JC, López-Zeno JA, Simmens S, Minior VK, Vintzileos AM: Placental pathologic features of preterm preeclampsia. Am J Obstet Gynecol 1995; 173: 1097-1105.
36. Arias F, Victoria A, Cho K, Kraus F: Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol 1997; 89: 265-271.
37. Redline RW, Ariel I, Baergen RN, Desa DJ, Kraus FT, Roberts DJ, Sander CM; The Society for Pediatric Pathology, Perinatal Section, Fetal Vascular Obstruction Nosology Committee: Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2004; 7: 443-452.
38. Lin S, Shimizu I, Suehara N, Nakayama M, Aono T: Uterine artery Doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed. Obstet Gynecol 1995; 85: 760-765.
39. Salafia CM, Pezzullo JC, Minior VK, Divon MY: Placental pathology of absent and reversed end-diastolic flow in growth-restricted fetuses. Obstet Gynecol 1997; 90: 830-836.
40. FitzGerald DE, Drumm JE: Non-invasive measurement of human fetal circulation using ultrasound: a new method. Br Med J 1977; 2: 1450-1451.
41. Erskine RL, Ritchie JW: Umbilical artery blood flow characteristics in normal and growth-retarded fetuses. Br J Obstet Gynaecol 1985; 92: 605-610.
42. Trudinger BJ, Giles WB, Cook CM, Bombardieri J, Collins L: Fetal umbilical artery flow velocity waveforms and placental resistance: clinical significance. Br J Obstet Gynaecol 1985; 92: 23-30.
43. Nicolaides KH, Bilardo CM, Soothill PW, Campbell S: Absence of end-diastolic frequencies in umbilical artery: a sign of fetal hypoxia and acidosis. BMJ 1988; 297: 1026-1027.
44. Karsdorp VHM, van Vugt JMG, van Geijn HP, Kostense PJ, Arduim D, Montenegro N, Todros T: Clinical significance of absent or reversed end diastolic velocity waveforms in umbilical artery. Lancet 1994; 344: 1664-1668.
45. Sebire NJ: Umbilical artery Doppler revisited: pathophysiology of changes in intrauterine growth restriction revealed. Ultrasound Obstet Gynecol 2003; 21: 419-422.
46. Campbell S, Pearce JM, Hackett G, Cohen-Overbeek T, Hernandez C: Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies. Obstet Gynecol 1986; 68: 649-653.
47. Bewley S, Cooper D, Campbell S: Doppler investigation of uteroplacental blood flow resistance in the second trimester: a screening study for pre-eclampsia and intrauterine growth retardation. Br J Obstet Gynaecol 1991; 98: 871-879.
48. Las Heras J, Baskerville JC, Harding PG, Haust MD: Morphometric studies of fetal placental stem arteries in hypertensive disorders ('toxaemia') of pregnancy. Placenta 1985; 6: 217-227.
49. Fok RY, Pavlova Z, Benirschke K, Paul RH, Platt LD: The correlation of arterial lesions with umbilical artery Doppler velocimetry in the placentas of small-for-dates pregnancies. Obstet Gynecol 1990; 75: 578-583.
50. Mitra SC, Venkataseshan VS, Hagen von S, Barton PT, Delshad G, Gil J: Morphometric study of the placental vessels and its correlation with umbilical artery Doppler flow. Obstet Gynecol 1997; 89: 238-241.
51. Mitra SC, Seshan SV, Riachi LE: Placental vessel morphometry in growth retardation and increased resistance of the umbilical artery Doppler flow. J Matern Fetal Med 2000; 9: 282-286.
52. Hitschold T, Weiss E, Beck T, Hünterfering H, Berle P: Low target birth weight or growth retardation? Umbilical Doppler flow velocity waveforms and histometric analysis of fetoplacental vascular tree. Am J Obstet Gynecol 1993; 168: 1260-1264.
53. Jackson MR, Walsh AJ, Morrow RJ, Mullen JB, Lye SJ, Ritchie JW: Reduced placental villous tree elaboration in small-for-gestationalage pregnancies: relationship with umbilical artery Doppler waveforms. Am J Obstet Gynecol 1995; 172: 518-525.
54. Macara L, Kingdom JC, Kohnen G, Bowman AW, Greer IA, Kaufmann P: Elaboration of stem villous vessels in growth restricted pregnancies with abnormal umbilical artery Doppler waveforms. Br J Obstet Gynaecol 1995; 102: 807-812.
55. Turan OM, Turan S, Gungor S, Berg C, Moyano D, Gembruch U, Nicolaides KH, Harman CR, Baschat AA: Progression of Doppler abnormalities in intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 32: 160-167.
56. Redline RW, Pappin A: Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. Hum Pathol 1995; 26: 80-85.
57. Kim T-H, Lee H-H, Chung S-H, Park J, Kwak JJ: Fetal thrombotic vasculopathy accompanied by fetal growth restriction. J Matern Fetal Neonatal Med 2013, Epub ahead of print.
58. Stock MK, Anderson DF, Phernetton TM, McLaughlin MK, Rankin JH: Vascular response of the fetal placenta to local occlusion of the maternal placental vasculature. J Dev Physiol 1980; 2: 339-346.
59. Lang U, Baker RS, Khoury J, Clark KE: Fetal umbilical vascular response to chronic reductions in uteroplacental blood flow in late-term sheep. Am J Obstet Gynecol 2002; 187: 178-186.
60. Howard RB, Hosokawa T, Maguire MH: Hypoxia-induced fetoplacental vasoconstriction in perfused human placental cotyledons. Am J Obstet Gynecol 1987; 157: 1261-1266.
61. Hampl V, Bíbová J, Stranák Z, Wu X, Michelakis ED, Hashimoto K, Archer SL: Hypoxic fetoplacental vasoconstriction in humans is mediated by potassium channel inhibition. Am J Physiol Heart Circ Physiol 2002; 283:H2440-H2449.
62. Jakoubek V, Bíbová J, Hampl V: Voltage-gated calcium channels mediate hypoxic vasoconstriction in the human placenta. Placenta 2006; 27: 1030-1033.
63. Wareing M, Greenwood SL, Taggart MJ, Baker PN: Vasoactive responses of veins isolated from the human placental chorionic plate. Placenta 2003; 24: 790-796.
64. Wareing M, Greenwood SL, Baker PN: Reactivity of human placental chorionic plate vessels is modified by level of oxygenation: differences between arteries and veins. Placenta 2006; 27: 42-48.
65. Sebire NJ, Talbert D: The role of intraplacental vascular smooth muscle in the dynamic placenta: A conceptual framework for understanding uteroplacental disease. Med Hypotheses 2002; 58: 347-351.
66. Talbert D, Sebire NJ: The dynamic placenta: I. Hypothetical model of a placental mechanism matching local fetal blood flow to local intervillus oxygen delivery. Med Hypotheses 2004; 62: 511-519.
67. Sebire NJ, Talbert D: The dynamic placenta: II. Hypothetical model of a fetus driven transplacental water balance mechanism producing low apparent permeability in a highly permeable placenta. Med Hypotheses 2004; 62: 520-528.
68. Cindrova-Davies T, Herrera EA, Niu Y, Kingdom J, Giussani DA, Burton GJ: Reduced cystathionine γ-lyase and increased miR-21 expression are associated with increased vascular resistance in growth-restricted pregnancies: hydrogen sulfide as a placental vasodilator. Am J Pathol 2013; 182: 1448-1458.
69. Mortimer GG, MacDonald DJD, Smeeth AA: A pilot study of the frequency and significance of placental villitis. Br J Obstet Gynaecol 1985; 92: 629-633.
70. Nordenvall M, Ullberg U, Laurin J, Lingman G, Sandstedt B, Ulmsten U: Placental morphology in relation to umbilical artery blood velocity waveforms. Eur J Obstet Gynecol Reprod Biol 1991; 40: 179-190.
71. Salafia CM, Vogel CA, Bantham KF, Vintzileos AM, Pezzullo J, Silberman L: Preterm delivery: correlations of fetal growth and placental pathology. Am J Perinatol 1992; 9: 190-193.
72. Redline RWR, Patterson PP: Patterns of placental injury. Correlations with gestational age, placental weight, and clinical diagnoses. Arch Pathol Lab Med 1994; 118: 698-701.
73. Russell P, Atkinson K, Krishnan L: Recurrent reproductive failure due to severe placental villitis of unknown etiology. J Reprod Med 1980; 24: 93-98.
74. Redline RW, Abramowsky CR: Clinical and pathologic aspects of recurrent placental villitis. Hum Pathol 1985; 16: 727-731.
75. Styer AK, Parker HJ, Roberts DJ, Palmer-Toy D, Toth TL, Ecker JL: Placental villitis of unclear etiology during ovum donor in vitro fertilization pregnancy. Am J Obstet Gynecol 2003; 189: 1184-1186.
76. Althaus J, Weir EG, Askin F, Kickler TS, Blakemore K: Chronic villitis in untreated neonatal alloimmune thrombocytopenia: an etiology for severe early intrauterine growth restriction and the effect of intravenous immunoglobulin therapy. Am J Obstet Gynecol 2005; 193: 1100-1104.
77. Perni SC, Predanik M, Cho JE, Baergen RN: Placental pathology and pregnancy outcomes in donor and non-donor oocyte in vitro fertilization pregnancies. J Perinat Med 2005; 33: 27-32.
78. Becroft DM, Thompson JM, Mitchell EA: Placental villitis of unknown origin: epidemiologic associations. Am J Obstet Gynecol 2005; 192: 264-271.
79. Jacques SM, Qureshi F: Chronic villitis of unknown etiology in twin gestations. Pediatr Pathol 1994; 14: 575-584.
80. Redline RW: Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol 2007; 38: 1439-1446.
81. Khong TY, Staples A, Moore L, Byard RW: Observer reliability in assessing villitis of unknown aetiology. J Clin Pathol 1993; 46: 208-210.
82. Labarrere C, Althabe O: Chronic villitis of unknown etiology and maternal arterial lesions in preeclamptic pregnancies. Eur J Obstet Gynecol Reprod Biol 1985; 20: 1-11.
83. Pathak S, Lees CC, Hackett G, Jessop F, Sebire NJ: Frequency and clinical significance of placental histological lesions in an unselected population at or near term. Virchows Arch 2011; 459: 565-572.
84. Odegård RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R: Preeclampsia and fetal growth. Obstet Gynecol 2000; 96: 950-955.
85. Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B: The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol 2003; 189: 1173-1177.
86. Sebire NJ, Goldin RD, Regan L: Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity. J Obstet Gynaecol 2005; 25: 117-118.
87. Ogge G, Chaiworapongsa T, Romero R, Hussein Y, Kusanovic JP, Yeo L, Kim CJ, Hassan SS: Placental lesions associated with maternal underperfusion are more frequent in earlyonset than in late-onset preeclampsia. J Perinat Med 2011; 39: 641-652.
88. Nelson DB, Ziadie MS, McIntire DD, Rogers BB, Leveno KJ: Placental pathology suggesting that preeclampsia is more than one disease. Am J Obstet Gynecol 2014; 210: 66e1-e7.
89. Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH; Fetal Medicine Foundation Second Trimester Screening Group: Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18: 441-449.
90. Papageorghiou AT, Yu CKH, Cicero S, Bower S, Nicolaides KH: Second-trimester uterine artery Doppler screening in unselected populations: a review. J Matern Fetal Neonatal Med 2002; 12: 78-88.
91. Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH: Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18: 583-586.
92. Melchiorre K, Wormald B, Leslie K, Bhide A, Thilaganathan B: First-trimester uterine artery Doppler indices in term and preterm preeclampsia. Ultrasound Obstet Gynecol 2008; 32: 133-137.
93. Scifres CM, Nelson DM: Intrauterine growth restriction, human placental development and trophoblast cell death. J Physiol (Lond) 2009; 587: 3453-3458.
94. Maynard SE, Min J-Y, Merchan J, Lim K-H, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658.
95. Levine RJ, Maynard SE, Qian C, Lim K-H, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-683.
96. Chaiworapongsa T, Romero R, Kim YM, Kim GJ, Kim MR, Espinoza J, Bujold E, Gonçalves L, Gomez R, Edwin S, Mazor M: Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 2005; 17: 3-18.
97. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, Gotsch F, Erez O, Mazaki-Tovi S, Gomez R, Edwin S, Chaiworapongsa T, Levine RJ, Karumanchi SA: A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008; 21: 9-23.
98. Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Edwin SS, Gomez R, Yeo L, Conde-Agudelo A, Hassan SS: A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med 2009; 22: 1021-1038.
99. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ: Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 2010; 122: 478-487.
100. Rana S, Schnettler WT, Powe C, Wenger J, Salahuddin S, Cerdeira AS, Verlohren S, Perschel FH, Arany Z, Lim K-H, Thadhani R, Karumanchi SA: Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens Pregnancy 2013; 32: 189-201.
101. Apel-Sarid L, Levy A, Holcberg G, Sheiner E: Term and preterm (<34 and <37 weeks' gestation) placental pathologies associated with fetal growth restriction. Arch Gynecol Obstet 2010; 282:487-492.
102. Kovo M, Schreiber L, Ben-Haroush A, Wand S, Golan A, Bar J: Placental vascular lesion differences in pregnancy-induced hypertension and normotensive fetal growth restriction. Am J Obstet Gynecol 2010; 202: 561.e1-e5.
103. Althabe O, Labarrere C: Chronic villitis of unknown aetiology and intrauterine growthretarded infants of normal and low ponderal index. Placenta 1985; 6: 369-373.
104. Redline RW, Boyd T, Campbell V, Hyde S, Kaplan C, Khong TY, Prashner HR, Waters BL, Society for Pediatric Pathology, Perinatal Section, Maternal Vascular Perfusion Nosology Committee: Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2004; 7: 237-249.
105. Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler C: Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2003; 6: 435-448.
106. Edgar R, Domrachev M, Lash AE: Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002; 30: 207-210.
107. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, Yefanov A, Lee H, Zhang N, Robertson CL, Serova N, Davis S, Soboleva A: NCBI GEO: Archive for functional genomics datasets-update. Nucleic Acids Res 2013; 41:D991-D995.
108. Hipp JD, Lucas DR, Emmert-Buck MR, Compton CC, Balis UJ: Digital slide repositories for publications: lessons learned from the microarray community. Am J Surg Pathol 2011; 35: 783-786.